verapamil has been researched along with Tuberculosis, Drug-Resistant in 9 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil and reserpine were included to determine their effect on rifampicin and ofloxacin susceptibility." | 1.37 | Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. ( Gey van Pittius, NC; Grobbelaar, M; Hernandez-Pando, R; Jimenez, A; Leon, R; Louw, GE; McEvoy, CR; Murray, M; van Helden, PD; Victor, TC; Warren, RM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Özgür, D | 1 |
| Ersoy, L | 1 |
| Ülger, M | 1 |
| Tezcan Ülger, S | 1 |
| Aslan, G | 1 |
| Mushtaq, F | 1 |
| Raza, SM | 1 |
| Ahmad, A | 1 |
| Aslam, H | 1 |
| Adeel, A | 1 |
| Saleem, S | 1 |
| Ahmad, I | 1 |
| de Souza, JVP | 1 |
| Murase, LS | 2 |
| Caleffi-Ferracioli, KR | 3 |
| Palomo, CT | 1 |
| de Lima Scodro, RB | 1 |
| Siqueira, VLD | 1 |
| Pavan, FR | 2 |
| Cardoso, RF | 3 |
| de Souza, JV | 1 |
| Canezin, PH | 2 |
| Scodro, RB | 2 |
| Ld Siqueira, V | 1 |
| Gupta, S | 1 |
| Cohen, KA | 1 |
| Winglee, K | 1 |
| Maiga, M | 1 |
| Diarra, B | 1 |
| Bishai, WR | 1 |
| Demitto, Fde O | 1 |
| do Amaral, RC | 1 |
| Maltempe, FG | 1 |
| Siqueira, VL | 1 |
| Lopes, MA | 1 |
| Ramos, DF | 1 |
| Almeida da Silva, PE | 1 |
| Louw, GE | 1 |
| Warren, RM | 1 |
| Gey van Pittius, NC | 1 |
| Leon, R | 1 |
| Jimenez, A | 1 |
| Hernandez-Pando, R | 1 |
| McEvoy, CR | 1 |
| Grobbelaar, M | 1 |
| Murray, M | 1 |
| van Helden, PD | 1 |
| Victor, TC | 1 |
| Machado, D | 1 |
| Couto, I | 1 |
| Perdigão, J | 1 |
| Rodrigues, L | 1 |
| Portugal, I | 1 |
| Baptista, P | 1 |
| Veigas, B | 1 |
| Amaral, L | 1 |
| Viveiros, M | 1 |
9 other studies available for verapamil and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
[Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
Topics: Antitubercular Agents; Bacterial Proteins; DNA, Complementary; Humans; Isoniazid; Microbial Sensitiv | 2023 |
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure.
Topics: Amikacin; Antitubercular Agents; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Moxiflox | 2023 |
Isoniazid and verapamil modulatory activity and efflux pump gene expression in
Topics: Antitubercular Agents; Bacterial Proteins; Gene Expression; Humans; Isoniazid; Membrane Transport Pr | 2020 |
Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Brazil; Catalase; DNA-Directed RNA Polymerases; Drug Resi | 2019 |
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Diarylquinolines; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tu | 2014 |
In vitro activity of rifampicin and verapamil combination in multidrug-resistant mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Calcium Channel Blockers; Drug Resistance, Multiple, Bacterial; Ethidiu | 2015 |
Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Topics: Anti-Bacterial Agents; Benzofurans; Calcium Channel Blockers; Carbonyl Cyanide m-Chlorophenyl Hydraz | 2010 |
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacterial | 2011 |
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Biological Transport, Active; Carrier Proteins; Catalase; | 2012 |